[CIS PIDD] [cis-pidd] VS: IVIG or SCIG

[CIS-PIDD]

Interesting thought, Mikko.  I will pass on to the managing MD.  Joe Church

From: cis-pidd at lyris.dundee.net [mailto:cis-pidd at lyris.dundee.net] On Behalf Of CIS-PIDD
Sent: Tuesday, June 06, 2017 10:56 PM
To: CIS-PIDD
Subject: Re: [cis-pidd] VS: IVIG or SCIG (EXTERNAL EMAIL)

Is there a contraindication for anti platelet therapy?

On Jun 7, 2017, at 08:32, CIS-PIDD <cis-pidd at lists.clinimmsoc.org<mailto:cis-pidd at lists.clinimmsoc.org>> wrote:
Out of I think 3 such CVID patients I have seen, 1 had recurrent thrombosis, but that was before present day preparations and she had multiple (!) other risk factors.

If she refuses SCIG (which I would prefer) would then use IVIG.

Mikko



Mikko Seppänen
Director, Adjunct Professor, MD, PhD
Hospital District of Helsinki and Uusimaa, Children’s Hospital, Rare Disease Center
P.O.Box 280, 00029 HUS |Lastenlinnantie 2, Helsinki
Senior Consultant
Hospital District of Helsinki and Uusimaa, Inflammation Center, Adult Primary Immunodeficiency Outpatient Clinic
mikko.seppanen at hus.fi<mailto:mikko.seppanen at hus.fi>
+358 9 47180201<image001.gif>| +358 50 4279606
faxi +358 9 47174703
www.hus.fi<http://www.hus.fi/>; www.harvinaissairaudet.fi<http://www.harvinaissairaudet.fi/>

 <image002.jpg>




Lähettäjä: cis-pidd at lyris.dundee.net<mailto:cis-pidd at lyris.dundee.net> [mailto:cis-pidd at lyris.dundee.net] Puolesta CIS-PIDD
Lähetetty: 6. kesäkuuta 2017 18:53
Vastaanottaja: CIS-PIDD <cis-pidd at lyris.dundee.net<mailto:cis-pidd at lyris.dundee.net>>
Aihe: [cis-pidd] IVIG or SCIG

Colleagues:

I consulted on a 46yo F who requires immunoglobulin replacement therapy.  She is s/p bilateral mastectomy for breast cancer and on tamoxifen as maintenance.

Tamoxifen “slightly” increases the risk for DVTs etc.

However, the patient would prefer IVIG over SCIG.

Does anyone have experience with the combination of IVIG + tamoxifen and the risk of thrombotic events?

Thank you for your help.

Joe Church
Children’s Hospital Los Angeles



.

CONFIDENTIALITY NOTICE: This e-mail message, including any attachments,
is for the sole use of the intended recipient(s) and may contain confidential
or legally privileged information. Any unauthorized review, use, disclosure
or distribution is prohibited. If you are not the intended recipient, please
contact the sender by reply e-mail and destroy all copies of this original message.

---

You are currently subscribed to cis-pidd as: mikko.seppanen at hus.fi<mailto:mikko.seppanen at hus.fi>.

To unsubscribe click here: http://cts.dundee.net/u?id=99266512.00d254228cd4b291924022bf56fac1f0&n=T&l=cis-pidd&o=4415146

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to leave-4415146-99266512.00d254228cd4b291924022bf56fac1f0 at lyris.dundee.net<mailto:leave-4415146-99266512.00d254228cd4b291924022bf56fac1f0 at lyris.dundee.net>

---

You are currently subscribed to cis-pidd as: shidave at gmail.com<mailto:shidave at gmail.com>.

To unsubscribe click here: http://cts.dundee.net/u?id=104312920.b95357c06f6e1b971ba6b89dfa47ac0d&n=T&l=cis-pidd&o=4416176

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to leave-4416176-104312920.b95357c06f6e1b971ba6b89dfa47ac0d at lyris.dundee.net<mailto:leave-4416176-104312920.b95357c06f6e1b971ba6b89dfa47ac0d at lyris.dundee.net>

---

You are currently subscribed to cis-pidd as: jchurch at chla.usc.edu<mailto:jchurch at chla.usc.edu>.

To unsubscribe click here: http://cts.dundee.net/u?id=96396658.df9245d5219d19fc82ac9f3bbf52c836&n=T&l=cis-pidd&o=4416193

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to leave-4416193-96396658.df9245d5219d19fc82ac9f3bbf52c836 at lyris.dundee.net<mailto:leave-4416193-96396658.df9245d5219d19fc82ac9f3bbf52c836 at lyris.dundee.net>

CONFIDENTIALITY NOTICE: This e-mail message, including any attachments, 
is for the sole use of the intended recipient(s) and may contain confidential
or legally privileged information. Any unauthorized review, use, disclosure
or distribution is prohibited. If you are not the intended recipient, please
contact the sender by reply e-mail and destroy all copies of this original message.  

---
You are currently subscribed to cis-pidd as: pagid at list.clinimmsoc.org.
To unsubscribe click here: http://cts.dundee.net/u?id=96396833.5a9591ccd1e327fe6bc4d1543298c482&n=T&l=cis-pidd&o=4416761
or send a blank email to leave-4416761-96396833.5a9591ccd1e327fe6bc4d1543298c482 at lyris.dundee.net
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://pairlist7.pair.net/pipermail/pagid/attachments/20170607/e619ae51/attachment-0001.html>